HASHEM EL-SERAG to Antineoplastic Agents
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Antineoplastic Agents.
Connection Strength
0.179
-
How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
Score: 0.070
-
Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 2012 Jan; 46(1):71-7.
Score: 0.045
-
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2009 Jun; 55(2):123-38.
Score: 0.038
-
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9.
Score: 0.015
-
Hepatocellular carcinoma at the cutting edge of science and practice. Minerva Med. 2010 Dec; 101(6):391-3.
Score: 0.011